Abstract | BACKGROUND: MATERIALS AND METHODS: The effects of DBP-MAF on proliferation, morphology, vimentin expression and angiogenesis were studied by cell proliferation assay, phase-contrast microscopy, immunohistochemistry and western blotting, and chorioallantoic membrane (CAM) assay. RESULTS:
DBP-MAF inhibited human breast cancer cell proliferation and cancer cell-stimulated angiogenesis. MCF-7 cells treated with DBP-MAF predominantly grew in monolayer and appeared to be well adherent to each other and to the well surface. Exposure to DBP-MAF significantly reduced vimentin expression, indicating a reversal of the epithelial/mesenchymal transition, a hallmark of human breast cancer progression. CONCLUSION: These results are consistent with the hypothesis that the known anticancer efficacy of DBP-MAF can be ascribed to different biological properties of the molecule that include inhibition of tumour-induced angiogenesis and direct inhibition of cancer cell proliferation, migration and metastatic potential.
|
Authors | Stefania Pacini, Tiziana Punzi, Gabriele Morucci, Massimo Gulisano, Marco Ruggiero |
Journal | Anticancer research
(Anticancer Res)
Vol. 32
Issue 1
Pg. 45-52
(Jan 2012)
ISSN: 1791-7530 [Electronic] Greece |
PMID | 22213287
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Macrophage-Activating Factors
- Vimentin
- Vitamin D-Binding Protein
- vitamin D-binding protein-macrophage activating factor
|
Topics |
- Blotting, Western
- Breast Neoplasms
(blood supply, metabolism, pathology)
- Cell Movement
- Cell Proliferation
- Chorioallantoic Membrane
(metabolism)
- Female
- Humans
- Macrophage-Activating Factors
(metabolism)
- Microscopy, Phase-Contrast
- Neovascularization, Pathologic
- Tumor Cells, Cultured
- Vimentin
(metabolism)
- Vitamin D-Binding Protein
(metabolism)
|